Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Friedrich, G; Ott, E.
Prospective randomized study on the comparative effect between 10% HES 200/0.5 and 6% HES 200/0.5 in patients with hearing loss
Laryngorhinootologie. 1991; 70(12): 670-674.
Doi: 10.1055/s-2007-998121
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Ott Erwin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Two good comparable groups of patients (group 1 treated with 10% HES 200/0.5 + Naftidrofuryl; and group 2 treated with 6% HES 200/0.5 + Naftidrofuryl) with sudden hearing loss were compared with respect to their hearing recovery, hemorheological parameters and intravasal detectable HES fraction. The results showed an overall improvement of the hemorheological features. No difference between the two groups could be found wether in the hearing improvement nor the investigated parameters. We therefore conclude, that HES 6% is a good alternative to HES 10% for hemodilution therapy in cochleo-vestibular disorders.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Audiometry - methods
- Dose-Response Relationship, Drug - methods
- Drug Administration Schedule - methods
- Female - methods
- Hearing Loss, Sudden - drug therapy
- Hemodilution - methods
- Hetastarch - methods
- Humans - methods
- Male - methods
- Middle Aged - methods
- Nafronyl - administration and dosage
- Prospective Studies - administration and dosage
- Vestibular Function Tests - administration and dosage